US$ 22.74
glp 1 and stroke The Paper of The Month - September Emerging Treatments for Obesity: the
Description
The two pathways converge on the same outcome, reduced food intake, but they get there through different neurological routes

Yet research examining these newer agents as early interventions for those showing minimal initial response remains scarce

If something here raises a question, follow the links that feel most relevant and ignore the rest for now

There are real biological reasons GLP-1 drugs could help with neurodegeneration and mental ill-health

Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells

Chem Senses (2013) 38(1):6775
